James Poling

5.4k total citations
69 papers, 4.1k citations indexed

About

James Poling is a scholar working on Cellular and Molecular Neuroscience, Epidemiology and Pharmacology. According to data from OpenAlex, James Poling has authored 69 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cellular and Molecular Neuroscience, 27 papers in Epidemiology and 18 papers in Pharmacology. Recurrent topics in James Poling's work include Substance Abuse Treatment and Outcomes (27 papers), Neurotransmitter Receptor Influence on Behavior (27 papers) and Cannabis and Cannabinoid Research (12 papers). James Poling is often cited by papers focused on Substance Abuse Treatment and Outcomes (27 papers), Neurotransmitter Receptor Influence on Behavior (27 papers) and Cannabis and Cannabinoid Research (12 papers). James Poling collaborates with scholars based in United States, Netherlands and Japan. James Poling's co-authors include Mehmet Sofuoglu, Bruce J. Rounsaville, Thomas R. Kosten, Henry R. Kranzler, Joel Gelernter, Lindsay A. Farrer, Samuel A. Ball, Howard Tennen, Raymond F. Anton and Alison Oliveto and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biological Psychiatry.

In The Last Decade

James Poling

68 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Poling United States 35 1.3k 1.2k 1.2k 811 623 69 4.1k
John Grabowski United States 35 811 0.6× 1.7k 1.5× 1.1k 0.9× 774 1.0× 458 0.7× 85 3.8k
Gantt P. Galloway United States 34 711 0.5× 1.6k 1.3× 1.1k 1.0× 656 0.8× 303 0.5× 77 3.7k
Michel Reynaud France 33 730 0.6× 838 0.7× 881 0.7× 646 0.8× 329 0.5× 129 3.4k
Bryon Adinoff United States 42 856 0.7× 1.4k 1.2× 753 0.6× 416 0.5× 441 0.7× 147 5.0k
Michael Soyka Germany 33 1.1k 0.8× 935 0.8× 1.2k 1.0× 451 0.6× 346 0.6× 187 4.1k
Christian J. Hopfer United States 40 1.1k 0.9× 606 0.5× 1.2k 1.0× 1.1k 1.4× 516 0.8× 115 4.5k
Gerhard A. Wiesbeck Switzerland 34 591 0.5× 776 0.6× 924 0.8× 423 0.5× 371 0.6× 127 3.4k
Karen Miotto United States 33 635 0.5× 1.2k 1.0× 1.2k 1.0× 722 0.9× 386 0.6× 76 4.0k
Joseph F. Cubells United States 38 1.2k 0.9× 1.3k 1.1× 629 0.5× 429 0.5× 1.3k 2.1× 109 5.4k
Thomas F. Newton United States 39 586 0.5× 2.1k 1.8× 662 0.6× 973 1.2× 587 0.9× 123 4.7k

Countries citing papers authored by James Poling

Since Specialization
Citations

This map shows the geographic impact of James Poling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Poling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Poling more than expected).

Fields of papers citing papers by James Poling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Poling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Poling. The network helps show where James Poling may publish in the future.

Co-authorship network of co-authors of James Poling

This figure shows the co-authorship network connecting the top 25 collaborators of James Poling. A scholar is included among the top collaborators of James Poling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Poling. James Poling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zayats, Tetyana, Bao‐Zhu Yang, Pingxing Xie, et al.. (2013). A Complex Interplay between Personality Domains, Marital Status and a Variant in CHRNA5 on the Risks of Cocaine, Nicotine Dependences and Cocaine-Induced Paranoia. PLoS ONE. 8(1). e49368–e49368. 8 indexed citations
3.
Poling, James, et al.. (2010). The Safety and Efficacy of Varenicline in Cocaine Using Smokers Maintained on Methadone: A Pilot Study. American Journal on Addictions. 19(5). 401–408. 55 indexed citations
4.
Sewell, R. Andrew, James Poling, & Mehmet Sofuoglu. (2009). The Effect of Cannabis Compared with Alcohol on Driving. American Journal on Addictions. 18(3). 185–193. 243 indexed citations
5.
Zuo, Lingjun, Joel Gelernter, Henry R. Kranzler, et al.. (2009). ADH1A variation predisposes to personality traits and substance dependence. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 153B(2). 376–386. 13 indexed citations
6.
Martell, Bridget, Frank M. Orson, James Poling, et al.. (2009). Cocaine Vaccine for the Treatment of Cocaine Dependence in Methadone-Maintained Patients. Archives of General Psychiatry. 66(10). 1116–1116. 189 indexed citations
7.
Sofuoglu, Mehmet, James Poling, Kevin P. Hill, & Thomas R. Kosten. (2009). Atomoxetine Attenuates Dextroamphetamine Effects in Humans. The American Journal of Drug and Alcohol Abuse. 35(6). 412–416. 32 indexed citations
8.
Zuo, Lingjun, Henry R. Kranzler, Xingguang Luο, et al.. (2008). Interaction between Two Independent CNR1 Variants Increases Risk for Cocaine Dependence in European Americans: A Replication Study in Family-Based Sample and Population-Based Sample. Neuropsychopharmacology. 34(6). 1504–1513. 37 indexed citations
9.
Gelernter, Joel, Henry R. Kranzler, Carolien Panhuysen, et al.. (2008). Dense Genomewide Linkage Scan for Alcohol Dependence in African Americans: Significant Linkage on Chromosome 10. Biological Psychiatry. 65(2). 111–115. 28 indexed citations
10.
Yu, Yi, Henry R. Kranzler, Carolien Panhuysen, et al.. (2008). Substance dependence low-density whole genome association study in two distinct American populations. Human Genetics. 123(5). 495–506. 16 indexed citations
11.
Petrakis, Ismene L., Elizabeth Ralevski, Charla Nich, et al.. (2007). Naltrexone and Disulfiram in Patients With Alcohol Dependence and Current Depression. Journal of Clinical Psychopharmacology. 27(2). 160–165. 45 indexed citations
12.
Poling, James, Thomas R. Kosten, Kishorchandra Gonsai, et al.. (2007). Clinical Efficacy of Citalopram Alone or Augmented with Bupropion in Methadone-Stabilized Patients. American Journal on Addictions. 16(3). 187–194. 8 indexed citations
13.
Petrakis, Ismene L., James Poling, Carolyn Levinson, et al.. (2005). Naltrexone and Disulfiram in Patients with Alcohol Dependence and Comorbid Psychiatric Disorders. Biological Psychiatry. 57(10). 1128–1137. 117 indexed citations
14.
Petrakis, Ismene L., et al.. (2004). Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia. Psychopharmacology. 174(2). 300–300. 1 indexed citations
15.
González, Gerardo, Kevin A. Sevarino, Mehmet Sofuoglu, et al.. (2003). Tiagabine increases cocaine‐free urines in cocaine‐dependent methadone‐treated patients: results of a randomized pilot study. Addiction. 98(11). 1625–1632. 96 indexed citations
16.
Oliveto, Alison, et al.. (2003). D-cycloserine--naloxone interactions in opioid-dependent humans under a novel-response naloxone discrimination procedure.. Experimental and Clinical Psychopharmacology. 11(3). 237–246. 5 indexed citations
17.
Kosten, Thomas R., James Poling, & Alison Oliveto. (2003). Effects of reducing contingency management values on heroin and cocaine use for buprenorphine‐ and desipramine‐treated patients. Addiction. 98(5). 665–671. 17 indexed citations
18.
Verheul, R., et al.. (2000). Co‐occurrence of Axis I and Axis II disorders in substance abusers. Acta Psychiatrica Scandinavica. 101(2). 110–118. 39 indexed citations
19.
Poling, James, Bruce J. Rounsaville, Samuel A. Ball, et al.. (1999). Rates of Personality Disorders in Substance Abusers: A Comparison Between DSM-III-R and DSM-IV. Journal of Personality Disorders. 13(4). 375–384. 19 indexed citations
20.
Ball, Samuel A., Henry R. Kranzler, Howard Tennen, James Poling, & Bruce J. Rounsaville. (1998). Personality Disorder and Dimension Differences Between Type A and Type B Substance Abusers. Journal of Personality Disorders. 12(1). 1–12. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026